214. Efficacy of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, on Physical Function and Pain in Patients with Psoriatic Arthritis and Current Skin Involvement: Results of Palace 3, a Phase 3, Randomized, Controlled Trial

• Published in: Rheumatology (Oxford, England) Vol. 53; no. suppl_1; pp. i139 - i140
• Main Authors: Edwards, Christopher J., Blanco, Francisco J., Crowley, Jeffrey, Hu, ChiaChi, Stevens, Randall M., Birbara, Charles A.
• Format: Journal Article
• Language: English
• Published: 01.04.2014